Surgical versus nonsurgical treatment for lumbar degenerative spondylolisthesis

被引:621
|
作者
Weinstein, James N. [1 ]
Lurie, Jon D.
Tosteson, Tor D.
Hanscom, Brett
Tosteson, Anna N. A.
Blood, Emily A.
Birkmeyer, Nancy J. O.
Hilibrand, Alan S.
Herkowitz, Harry
Cammisa, Frank P.
Albert, Todd J.
Emery, Sanford E.
Lenke, Lawrence G.
Abdu, William A.
Longley, Michael
Errico, Thomas J.
Hu, Serena S.
机构
[1] Dartmouth Med Sch, Dept Orthopaed, Lebanon, NH 03756 USA
[2] Dartmouth Med Sch, Dept Med, Lebanon, NH USA
[3] Dartmouth Med Sch, Dept Community & Family Med, Lebanon, NH USA
[4] Univ Michigan, Ann Arbor, MI 48109 USA
[5] Thomas Jefferson Univ, Rothman Inst, Philadelphia, PA 19107 USA
[6] William H Beaumont Hosp, Royal Oak, MI USA
[7] Hosp Special Surg, New York, NY 10021 USA
[8] Univ Hosp Cleveland, Cleveland, OH 44106 USA
[9] Case Western Reserve Univ, Cleveland, OH 44106 USA
[10] Washington Univ, St Louis, MO 63130 USA
[11] Nebraska Fdn Hosp Spinal Res, Omaha, NE USA
[12] Hosp Joint Dis & Med Ctr, New York, NY USA
[13] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2007年 / 356卷 / 22期
关键词
D O I
10.1056/NEJMoa070302
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Management of degenerative spondylolisthesis with spinal stenosis is controversial. Surgery is widely used, but its effectiveness in comparison with that of nonsurgical treatment has not been demonstrated in controlled trials. METHODS: Surgical candidates from 13 centers in 11 U.S. states who had at least 12 weeks of symptoms and image-confirmed degenerative spondylolisthesis were offered enrollment in a randomized cohort or an observational cohort. Treatment was standard decompressive laminectomy (with or without fusion) or usual nonsurgical care. The primary outcome measures were the Medical Outcomes Study 36-Item Short-Form General Health Survey (SF-36) bodily pain and physical function scores (100-point scales, with higher scores indicating less severe symptoms) and the modified Oswestry Disability Index (100-point scale, with lower scores indicating less severe symptoms) at 6 weeks, 3 months, 6 months, 1 year, and 2 years. RESULTS: We enrolled 304 patients in the randomized cohort and 303 in the observational cohort. The baseline characteristics of the two cohorts were similar. The one-year crossover rates were high in the randomized cohort (approximately 40% in each direction) but moderate in the observational cohort (17% crossover to surgery and 3% crossover to nonsurgical care). The intention-to-treat analysis for the randomized cohort showed no statistically significant effects for the primary outcomes. The as-treated analysis for both cohorts combined showed a significant advantage for surgery at 3 months that increased at 1 year and diminished only slightly at 2 years. The treatment effects at 2 years were 18.1 for bodily pain (95% confidence interval [CI], 14.5 to 21.7), 18.3 for physical function (95% CI, 14.6 to 21.9), and -16.7 for the Oswestry Disability Index (95% CI, -19.5 to -13.9). There was little evidence of harm from either treatment. CONCLUSIONS: In nonrandomized as-treated comparisons with careful control for potentially confounding baseline factors, patients with degenerative spondylolisthesis and spinal stenosis treated surgically showed substantially greater improvement in pain and function during a period of 2 years than patients treated nonsurgically.
引用
收藏
页码:2257 / 2270
页数:14
相关论文
共 50 条
  • [41] Treatment for Degenerative Lumbar Spondylolisthesis: Current Concepts and New Evidence
    Samuel A.M.
    Moore H.G.
    Cunningham M.E.
    Current Reviews in Musculoskeletal Medicine, 2017, 10 (4) : 521 - 529
  • [42] Lateral Approaches for the Surgical Treatment of Lumbar Spondylolisthesis
    McGowan, Jason E.
    Kanter, Adam S.
    NEUROSURGERY CLINICS OF NORTH AMERICA, 2019, 30 (03) : 313 - +
  • [43] Is surgery more effective than nonsurgical treatment for the management of patients with degenerative spondylolisthesis?
    Gibson, J. N. A.
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (02): : 68 - 69
  • [44] Is surgery more effective than nonsurgical treatment for the management of patients with degenerative spondylolisthesis?
    JN Alastair Gibson
    Chye-Yew Ng
    Nature Clinical Practice Rheumatology, 2008, 4 : 68 - 69
  • [45] Cost-Effectiveness for Surgical Treatment of Degenerative Spondylolisthesis
    Jones, Kristen E.
    Polly, David W., Jr.
    NEUROSURGERY CLINICS OF NORTH AMERICA, 2019, 30 (03) : 365 - +
  • [46] An In Vitro Model of Degenerative Lumbar Spondylolisthesis
    Melnyk, Angela D.
    Kingwell, Stephen P.
    Zhu, Qingan
    Chak, Jason D.
    Cripton, Peter A.
    Fisher, Charles G.
    Dvorak, Marcel F.
    Oxland, Thomas R.
    SPINE, 2013, 38 (14) : E870 - E877
  • [47] Degenerative lumbar spondylolisthesis: Trends in management
    Majid, Kamran
    Fischgrund, Jeffrey S.
    JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS, 2008, 16 (04) : 208 - 215
  • [48] Lumbar Degenerative Spondylolisthesis Is Not Always Unstable
    Hasegawa, Kazuhiro
    Kitahara, Ko
    Shimoda, Haruka
    Ishii, Keiji
    Ono, Masatoshi
    Homma, Takao
    Watanabe, Kei
    SPINE, 2014, 39 (26) : 2127 - 2135
  • [49] Effectiveness of a Decision-Making Protocol for the Surgical Treatment of Lumbar Stenosis with Grade 1 Degenerative Spondylolisthesis
    Staartjes, Victor E.
    Schroder, Marc L.
    WORLD NEUROSURGERY, 2018, 110 : E355 - E361
  • [50] Surgical Outcomes of Minimally Invasive Transforaminal Lumbar Interbody Fusion for the Treatment of Spondylolisthesis and Degenerative Segmental Instability
    Park, Yung
    Ha, Joong Won
    Lee, Yun Tae
    Oh, Hyun Chul
    Yoo, Ju Hyung
    Kim, Hyung Bok
    ASIAN SPINE JOURNAL, 2011, 5 (04) : 228 - 236